A stereospecific myo-inositol D-chiro-inositol transporter in HepG2 liver cells - Identification with D-chiro-[3-H-3]inositol

被引:35
|
作者
Ostlund, RE
Seemayer, R
Gupta, S
Kimmel, R
Ostlund, EL
Sherman, WR
机构
[1] WASHINGTON UNIV,SCH MED,DIV METAB,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,DEPT PSYCHIAT,ST LOUIS,MO 63110
[3] GENENCOR INT INC,S SAN FRANCISCO,CA 94080
[4] AMER RADIOLABELED CHEM INC,ST LOUIS,MO 63146
关键词
D O I
10.1074/jbc.271.17.10073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
D-chiro-Inositol is an epimer of myo-inositol that is found in certain mammalian glycosylphosphatidylinositol protein anchors and inositol phosphoglycans possessing insulin-like bioactivity. In order to generate a probe for metabolic studies, D-chiro-[3-H-3]inositol was synthesized by selective reduction of D-chiro-3-inosose at pH 6.5 with sodium borotritide. D-chiro-[3-H-3]Inositol was taken up by HepG2 human liver cells through a saturable and stereospecific pathway in which D-chiro-inositol and myo-inositol competed equally but L-chiro-inositol was not recognized. D-Glucose, but not L-glucose, competed for D-chiro-[3-H-3]inositol uptake over glucose concentrations of 4-28 mM. Maximum transport capacity was 717 pmol/mg cell protein/3 h with a K-m value of 348 mu M. Uptake was reduced by 76% when sodium was eliminated from the medium and by 94% when the experiment was performed at 0 degrees C. The new myo/D-chiro-inositol transporter is distinct from the sodium-myo-inositol co-transporter found in many tissues and accounts for all of the saturable D-chiro-inositol uptake and for a portion of the saturable low affinity myo-inositol uptake in HepG2 cells. It may allow D-chiro-inositol to be used by cells in the presence of a relatively large amount of competing myo-inositol.
引用
收藏
页码:10073 / 10078
页数:6
相关论文
共 50 条
  • [1] From Myo-inositol to D-chiro-inositol molecular pathways
    Kiani, A. K.
    Paolacci, S.
    Calogero, A. E.
    Cannarella, R.
    Di Renzo, G. C.
    Gerli, S.
    Della Morte, C.
    Busetto, G. M.
    De Berardinis, E.
    Del Giudice, F.
    Stuppia, L.
    Facchinetti, F.
    Dinicola, S.
    Bertelli, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (05) : 2390 - 2402
  • [2] Myo-inositol/D-chiro-inositol metabolism in HIV lipodystrophy syndrome
    Placek, J
    Palmer, M
    Currier, J
    Vasquez, G
    ANTIVIRAL THERAPY, 2004, 9 (06) : L54 - L54
  • [3] Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition
    Tortolini, Cristina
    Gigli, Valeria
    Rizzo, Flavio
    Lenzi, Andrea
    Bizzarri, Mariano
    Angeloni, Antonio
    Antiochia, Riccarda
    SENSORS, 2023, 23 (22)
  • [4] Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review
    Bizzarri, Mariano
    Monti, Noemi
    Piombarolo, Aurora
    Angeloni, Antonio
    Verna, Roberto
    NUTRIENTS, 2023, 15 (08)
  • [5] myo-inositol oxygenase:: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol
    Arner, RJ
    Prabhu, KS
    Thompson, JT
    Hildenbrandt, GR
    Liken, AD
    Reddy, CC
    BIOCHEMICAL JOURNAL, 2001, 360 : 313 - 320
  • [6] The Rationale of the Myo-Inositol and D-Chiro-Inositol Combined Treatment for Polycystic Ovary Syndrome
    Dinicola, Simona
    Chiu, Tony T. Y.
    Unfer, Vittorio
    Carlomagno, Gianfranco
    Bizzarri, Mariano
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (10): : 1079 - 1092
  • [7] Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors
    Garzon, Simone
    Lagana, Antonio Simone
    Monastra, Giovanni
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (09) : 697 - 703
  • [8] Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
    Lete, Inaki
    Martinez, Ainara
    Lasaga, Irene
    Centurion, Eva
    Vesga, Amaia
    GYNECOLOGICAL ENDOCRINOLOGY, 2024, 40 (01)
  • [9] Effects of D-chiro-inositol and myo-inositol on the cataractogenesis of the xylose-induced rat lenses
    Lee, WK
    Kim, H
    FASEB JOURNAL, 2002, 16 (04): : A640 - A640
  • [10] Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome
    Unfer, Vittorio
    Porcaro, Giuseppina
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (05) : 623 - 631